Department of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Eur J Clin Invest. 2010 Apr;40(4):376-81. doi: 10.1111/j.1365-2362.2010.02259.x. Epub 2010 Feb 10.
The aim of this study was to investigate time course of procalcitonin (PCT), C-reactive protein (CRP) and white blood cell (WBC) levels in patients with therapeutic hypothermia after cardiac arrest.
We retrospectively assessed laboratory and clinical data in a consecutive cohort of patients admitted to the medical intensive-care-unit of the University Hospital in Basel, Switzerland, in whom therapeutic hypothermia was induced because of cardiac arrest between December 2007 and January 2009. Infection was considered based on microbiological evidence (restricted definition) and/or clinical evidence of infection with prescription of antibiotics (extended definition).
From 34 included patients, 25 had respiratory tract infection based on the clinical judgment and in 18 microbiological cultures turned positive (restricted definition). PCT concentrations were highest on the first day after hypothermia and showed a steady decrease until day 7 without differences in patients with and without presumed infection. CRP concentrations increased to a peak level at days 3-4 followed by a steady decrease; CRP concentrations were higher in patients with clinical diagnosis of infection on day 4 (P = 0.02); and in patients with evidence of bacterial growth in cultures on days 4 and 5 (P = 0.01 and P = 0.006). WBC remained unchanged after hypothermia without differences between patients with and without infection.
High initial values of PCT and high peak levels after 3-4 days of CRP were found in patients with induction of hypothermia after cardiac arrest. This increase was unspecific and mirrors rather an inflammatory reaction than true underlying infection, limiting the diagnostic potential for early antibiotic stewardship in these patients.
本研究旨在探讨心脏骤停后接受治疗性低温治疗患者降钙素原(PCT)、C 反应蛋白(CRP)和白细胞(WBC)水平的时间变化。
我们回顾性评估了瑞士巴塞尔大学医院重症监护病房连续收治的因心脏骤停而接受治疗性低温治疗的患者的实验室和临床数据。2007 年 12 月至 2009 年 1 月期间,这些患者因心脏骤停而接受了治疗性低温治疗。感染是根据微生物学证据(狭义定义)和/或感染的临床证据(伴有抗生素处方,广义定义)来判断的。
在 34 例纳入患者中,25 例根据临床判断患有下呼吸道感染,18 例微生物培养结果呈阳性(狭义定义)。PCT 浓度在低温治疗后第 1 天最高,呈持续下降趋势,直至第 7 天,在有无假定感染的患者中无差异。CRP 浓度在第 3-4 天达到峰值,随后持续下降;第 4 天有临床感染诊断的患者 CRP 浓度更高(P = 0.02);第 4 天和第 5 天有细菌培养阳性的患者 CRP 浓度更高(P = 0.01 和 P = 0.006)。低温治疗后 WBC 无变化,感染患者与无感染患者之间无差异。
心脏骤停后接受低温治疗的患者,PCT 初始值较高,第 3-4 天后 CRP 峰值较高。这种增加是不特异的,反映的更多是炎症反应,而不是真正的潜在感染,限制了这些患者早期抗生素管理的诊断潜力。